摘要
目的探讨和分析采取静脉溶栓法治疗急性心肌梗死患者的临床效果。方法选取102例经笔者治疗的急性心肌梗死患者为研究对象,采取随机数字标记法将上述选取对象分成对照组和观察组,对照组患者采取常规治疗的方法进行治疗,观察组患者采取静脉溶栓的方法进行治疗,观察和分析两组对象的血管再通率以及治疗过程中不良反应的发生率。结果对照组和观察组血管再通的患者人数依次为33例和43例,再通率依次为66.0%和82.7%,两组上述指标对比有显著性差异(P<0.05);治疗过程中,对照组和观察组发生不良反应的患者人数依次为8例和3例,不良反应发生率依次为16.0%和5.8%,两组对比有显著性差异(P<0.05)。结论使用尿激酶药物,采取静脉溶栓的方式对急性梗死患者进行治疗,安全系数高,治疗效果好,而且经济实惠,值得在广大基层医院进行推广。
Objective To investigate and analyze the clinical effect of intravenous thrombolysis in the treatment of acute myocardial infarction （AMI）. Methods A total of 102 AMI patients treated in our hospital were included in the study. These subjects were randomly divided into control group and observation group. The control group received conventional treatment, while the observation group received intravenous thrombolysis. The treatment outcomes of the two groups were analyzed based on revascularization rate and incidence of adverse events. Results In the control group, 33 patients （66.0%） had revasculafization, versus 43 patients （82.7%） in the observation group; there was significant difference in this index between the two groups （P〈0.05）. During treatment, 8 eases （16.0%） of the control group had adverse events, versus 3 cases （5.8%） of the observation group; there was significant difference in this index between the two groups （P〈0.05）. Conclusion Intravenous thrombolysis using urokinase has the advantages of high safety, good efficacy, and low cost in the treatment of AMI and holds promise for clinical application in primary hospitals.
出处
《心血管病防治知识（学术版）》
2014年第1期44-46,共3页
Prevention and Treatment of Cardiovascular Disease
关键词
急性心肌梗死
溶栓治疗
临床疗效
Acute myocardial infarction
Thrombolysis
Clinical effect
